Table 2.
Baseline characteristics | Treatment | P-value | Standardized difference | |
---|---|---|---|---|
PCI (N=420) | CABG (N=420) | |||
Female sex | 27.1% | 25.8% | 0.6679 | 0.03 |
Age (years) | 61.6±10.41 | 61.2 ±8.96 | 0.5472 | 0.042 |
Age >65 years | 34.6% | 32.3% | 0.4641 | 0.051 |
BMI (kg/m2) | 25.67±3.12 | 25.77±3.19 | 0.6527 | 0.031 |
Previous angina | 93.9% | 93.8% | 0.9645 | 0.003 |
Previous MI | 36.7% | 34.5% | 0.5141 | 0.045 |
Previous HF | 3% | 1.4% | 0.1111 | 0.109 |
Previous arrhythmia | 13.1% | 14.1% | 0.761 | 0.021 |
Stroke | 12.8% | 12.3% | 0.8333 | 0.015 |
TIA | 0.4% | 0% | 0.1518 | 0.008 |
PAD | 1.4% | 1.3% | 0.9109 | 0.084 |
Diabetes mellitus | 37.5% | 35.9% | 0.64 | 0.032 |
Hypertension | 82.7% | 82.9% | 0.9256 | 0.006 |
Dyslipidemia | 75.2% | 76.2% | 0.732 | 0.024 |
Chronic renal failure | 0 | 0 | NA | 0 |
COPD | 1.4% | 1.4% | 0.9292 | 0.006 |
Venous thromboembolism | 0.2% | 0% | 0.242 | 0.069 |
Current smoke | 35.4% | 35.3% | 0.9567 | 0.017 |
Cr (mg/dL) | 76.08±16.04 | 75.94 ±17.6 | 0.9051 | 0.008 |
Cr >133 mg/dL | 0.5% | 0.2% | 0.3457 | 0.064 |
LVEF (%) | 67.96±76.2 | 65.67±70.61 | 0.6523 | 0.031 |
NYHA | 0.7426 | 0.077 | ||
III | 6.1% | 4.7% | ||
IV | 0.3% | 0.6% | ||
Left main artery disease | 33.7% | 33.20% | 0.8717 | 0.011 |
CTO | 0.64±0.74 | 0.64±0.77 | 0.866 | 0.012 |
SYNTAX score | 0.8511 | 0.04 | ||
Low risk | 45.9% | 46.7% | ||
Median risk | 35.3% | 36% | ||
High risk | 18.8% | 17.3% | ||
EuroSCORE | 2.45±2.2 | 2.32±1.88 | 0.3612 | 0.063 |
PCI – percutaneous coronary intervention; CABG – coronary artery bypass surgery, BMI – body mass index; MI – myocardial infarction; HF – heart failure; TIA – transient ischemic attack; PAD – peripheral artery disease; COPD – chronic obstructive pulmonary disease; Cr – creatinine; LVEF – left ventricular ejection fraction; NYHA – New York Heart Association Functional Classification; CTO – chronic total occlusion.